Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_assertion type Assertion NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_head.
- NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_assertion description "[Selective orexin receptor antagonism takes advantage of these properties toward the development of novel insomnia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_provenance.
- NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_assertion evidence source_evidence_literature NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_provenance.
- NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_assertion SIO_000772 22759794 NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_provenance.
- NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_assertion wasDerivedFrom befree-20150227 NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_provenance.
- NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_assertion wasGeneratedBy ECO_0000203 NP445226.RANomGYGz-DhZZ5hVp4Wf8a4UiGHfYGKSClghMdGLTYr8130_provenance.